Objective: To propose a new criterion for the diagnosis of metabolic syndrome (MS) in adolescents and to check its consistency with those proposed by Jolliffe and Janssen and by the International Diabetes Federation (IDF).
Introduction
Metabolic syndrome (MS) is defined as a combination of clinical factors that include hypertension, dyslipidemias, glucose metabolic disorders, and obesity (especially abdominal), with intra-abdominal fat deposition. MS constitutes a group of risk factors for the development of cardiovascular diseases (CVD). 1, 2 The prevalence of MS among children and adolescents has increased concomitantly with the number of cases of obesity and its comorbidities. 3 Data from the National Health and Nutrition Examination Survey (NHANES) III (1988) (1989) (1990) (1991) (1992) and NHANES (1999 NHANES ( -2000 show an increase in the prevalence of MS from 4.2 to 6.4% in the population of U.S.
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Mônica de Lima Raeder Cavali, 1 Maria Arlete Meil Schimith Escrivão, 2 Rosana Sarmento Brasileiro, 3 José Augusto de Aguiar Carrazedo Taddei 4 adolescents. 4 A study of obese children and adolescents found an MS prevalence of 38.7 and 49.7% among those with moderate and severe obesity, respectively. 5 The prevalence of MS varies widely across several studies, and that is due to the different diagnostic criteria used. Reinehr et al. 6 compared the prevalence of MS in children and adolescents using eight different definitions.
The prevalence ranged from 6 to 39%, and only 2% met all the proposed criteria, thus underscoring the necessity for standardization of diagnostic criteria.
Several criteria for the diagnosis of MS in children and adolescents have already been proposed, 5, [7] [8] [9] but no consensus exists in the literature about the most appropriate one. The constant physiological changes in metabolism and in body composition, which occur in these age groups, hinder the adoption of specific cutoff points for the parameters used in this diagnosis. In addition, there is a paucity of long-term follow-up studies with children and adolescents that associate these values with future morbidities. The criterion for the diagnosis of MS in children and adolescents should include parameters that contemplate early-onset metabolic disorders in these individuals.
Weiss et al. 5 noted that insulin resistance (IR) was an independent factor for the diagnosis of MS in overweight children and adolescents and that the prevalence of MS increased as IR worsened.
The gold standard for measurement of IR is the euglycemic hyperinsulinemic clamp; however, it is not used in clinical practice. 10 The HOMA-IR (homeostasis model assessment -insulin resistance) index can be used as an alternative method for IR assessment as it has a good correlation with the euglycemic hyperinsulinemic clamp. 11 Chan et al. 12 Notwithstanding the difficulty in diagnosing MS, it is of paramount importance that children and adolescents that fulfill the criteria for this diagnosis be identified, as they are at greater metabolic risk and should therefore be properly monitored.
The aim of the present study is to propose a new diagnostic criterion for MS in obese adolescents and to check its consistency with those criteria proposed by Jolliffe Of 2,330 adolescents, 150 (6.43%) were diagnosed as obese. Among these, 26 (17.33%) met the exclusion criteria described above. Of the 124 remaining adolescents, 42 (33.87%) refused to take part in the study, and two (1.61%) quit the study during laboratory data collection.
The final sample consisted of 80 obese adolescents (64.5% of the initial sample). When the mean BMI values of the analyzed sample, stratified by age and sex, were compared with the mean BMI values of the 44 adolescents who did not participate in the study, no statistically significant differences were found between groups, indicating that losses to follow-up did not generate a selection bias. Likewise, the proportions in relation to age, sex and pubertal development were maintained.
A Kratos ® digital scale (model Linea) and a portable Alturaexata ® anthropometer, placed on a flat and sturdy surface, were used for the measurement of weight and height, respectively. Waist circumference (WC) was measured from the midpoint between the lowest rib and the iliac crest, using a nonstretch measuring tape. Blood pressure check and the diagnosis of hypertension followed the recommendations established by the National High
Blood Pressure Education Program Working Group on
High Blood Pressure in Children and Adolescents. 16 IR assessed by HOMA-IR 19 and steatosis. 20 Table 1 shows the parameters and the respective cutoff points, according to different criteria.
Descriptive statistics [mean, standard deviation and
95% confidence interval (95%CI)] was used for sample characterization, and the kappa coefficient was used to analyze agreement across the three diagnostic criteria for MS.
The statistical analyses were made using Stata 10.0. 22
Results
Of 80 adolescents, 33 (41.25%) were male. Mean age was 15,96 years, and mean BMI was 32.53 kg/m 2 ( cm; p = 0.000) than female adolescents, but there was no significant difference in BMI (p = 0.526). No significant difference was noted between mean levels of WC (p = 0.098), diastolic blood pressure (p = 0.336), triglycerides (p = 0.589), HDLc (p = 0.164) and HOMA (p = 0.28), in terms of sex, except for systolic blood pressure (p = 0.040). Steatosis was detected in 16.88%
of the study population (Table 2) , and was more frequent among male individuals (18.18 vs. 15.91%).
The prevalence of MS varied according to the criterion used: 13.75% in the IDF criterion; 15% in the Jolliffe & Janssen's criterion, and 25% in the proposed method. Among all adolescents diagnosed with IR, 70% had normal fasting glucose levels.
The hepatic ultrasound results revealed steatosis in 13 adolescents, seven of whom belonged to the group diagnosed with MS. It should be highlighted that five out of these seven adolescents were diagnosed with MS by the proposed method only, whereas the remaining two were diagnosed by the three criteria. Significant difference was observed in mean HOMA-IR indices when the presence or absence of steatosis was considered (4.68 vs. 3.05; p = 0.001). The mean HOMA-IR index was significantly higher in the presence of steatosis.
Discussion
The prevalence of MS in children and adolescents varies widely in the literature due to the different diagnostic criteria used. 6, 23, 24 Most of these criteria stem from criteria used for adults; thus, abnormal results that have a low frequency in children and adolescents, such as abnormal glucose levels, may be included in the requirements for this diagnosis.
In the present study, the prevalence of MS varied according to the criterion used: 13.75% for the IDF criterion, 15% for Jolliffe & Janssen's criterion and 25%
for the proposed method. Other authors, who compared the prevalence of MS using different criteria, also found variation in prevalence rates. 23, 24 The large agreement in MS prevalence between Jolliffe & Janssen's and IDF criteria can be explained by the use of the same parameters, but of different cutoff points. 30 observed reduction in intrahepatic triglycerides in magnetic resonance, as well as improvement in insulin sensitivity in obese adolescents after a weight management program. In the present study, hepatic steatosis was detected by ultrasound, which can be easily performed;
however, according to Saadeh et al., 31 this exam detects abnormalities only after hepatic parenchyma involvement is greater than 33%, which is revealed by biopsy. Steatosis was found in 13 adolescents, and was associated with IR in seven, suggesting that it should be investigated in the presence of IR. Its inclusion in the diagnosis of MS may allow for the identification of individuals at higher metabolic risk.
Conclusions
The prevalence of MS varied according to the diagnostic criterion used. The higher prevalence was detected by the method proposed in the present study, which included IR and hepatic steatosis among its parameters, thus being able to diagnose a larger number of adolescents at metabolic risk. The proposed method diagnosed more MS cases than the other two criteria because it used IR instead of glucose level as parameter for glucose metabolic findings. Glucose tends to show abnormal levels at a later stage of MS in children and adolescents.
It is important to identify children and adolescents who meet the criteria for the diagnosis of MS, as these individuals are at higher metabolic risk and should therefore be properly monitored. The persistence of these findings may favor the development of type 2 diabetes mellitus and of CVD in adulthood.
